1852 A phase II trial of docetaxel plus carboplatin plus bevacizumab as neoadjuvant therapy for triple negative breast cancer
Chacón López-Muñiz, J.I., Cárdenas, J.D., Santos Rodríguez, A.K., Esteban Esteban, M.C., Muñoz Platón, E., Rubio Salvador, A.R., Alonso Soler, S.E., Fernández Franco, L., San Juan del Moral, A., BurguVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30802-4
Date:
September, 2015
File:
PDF, 60 KB
english, 2015